IL21
Basic information
Region (hg38): 4:122610108-122621066
Links
Phenotypes
GenCC
Source:
- IL21-related infantile inflammatory bowel disease (Supportive), mode of inheritance: AR
- IL21-related infantile inflammatory bowel disease (Limited), mode of inheritance: Unknown
- common variable immunodeficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency, common variable, 11 | AR | Allergy/Immunology/Infectious | Individuals have been described as manifesting with primary immunodeficiency (with sequelae including severe inflammatory bowel disease, as well as recurrent/severe respiratory infections) and recognition may allow prophylactic measures and early and aggressive treatment of infections | Allergy/Immunology/Infectious | 24746753 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL21 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 41 | 42 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 4 | 5 | |||
non coding | 16 | 22 | ||||
Total | 0 | 0 | 43 | 26 | 8 |
Variants in IL21
This is a list of pathogenic ClinVar variants found in the IL21 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-122612665-C-T | Benign (Jun 20, 2021) | |||
4-122612679-G-A | Benign (Jun 20, 2021) | |||
4-122612707-T-G | IL21-related disorder | Benign (Sep 30, 2019) | ||
4-122612712-A-G | Uncertain significance (Sep 25, 2022) | |||
4-122612714-G-C | Uncertain significance (Jan 03, 2022) | |||
4-122612724-T-G | Uncertain significance (Nov 27, 2019) | |||
4-122612727-C-T | Uncertain significance (Oct 05, 2023) | |||
4-122612728-G-A | Benign (Jan 10, 2024) | |||
4-122612729-T-A | Uncertain significance (Aug 26, 2019) | |||
4-122612748-G-A | Uncertain significance (Dec 03, 2018) | |||
4-122612755-A-G | Likely benign (Aug 04, 2023) | |||
4-122612778-C-T | Likely benign (Dec 04, 2022) | |||
4-122612779-G-A | Likely benign (Dec 28, 2023) | |||
4-122612808-GTAAAGATAAAGCAGAAAATCAAATGAAACTTAAGGTAGATAC-G | Uncertain significance (Nov 20, 2020) | |||
4-122612835-A-T | Likely benign (Aug 17, 2023) | |||
4-122612845-A-G | Uncertain significance (Jan 26, 2021) | |||
4-122612851-C-A | Uncertain significance (Nov 20, 2020) | |||
4-122612864-G-A | Uncertain significance (Jan 10, 2024) | |||
4-122612884-T-A | Uncertain significance (Nov 01, 2022) | |||
4-122612895-G-A | Uncertain significance (Oct 13, 2022) | |||
4-122612895-G-T | Uncertain significance (Dec 08, 2023) | |||
4-122612935-A-G | Likely benign (Jan 06, 2021) | |||
4-122612945-AAGTAAC-A | Likely benign (Jun 03, 2023) | |||
4-122612946-A-C | Likely benign (Oct 07, 2022) | |||
4-122612947-G-A | Likely benign (Mar 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL21 | protein_coding | protein_coding | ENST00000264497 | 5 | 8442 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.625 | 0.368 | 125410 | 0 | 1 | 125411 | 0.00000399 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.54 | 44 | 83.6 | 0.527 | 0.00000395 | 1066 |
Missense in Polyphen | 5 | 22.159 | 0.22564 | 294 | ||
Synonymous | 2.56 | 11 | 28.3 | 0.388 | 0.00000131 | 292 |
Loss of Function | 2.18 | 1 | 7.38 | 0.136 | 3.10e-7 | 100 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000881 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytokine with immunoregulatory activity. May promote the transition between innate and adaptive immunity. Induces the production of IgG(1) and IgG(3) in B-cells (By similarity). May play a role in proliferation and maturation of natural killer (NK) cells in synergy with IL15. May regulate proliferation of mature B- and T-cells in response to activating stimuli. In synergy with IL15 and IL18 stimulates interferon gamma production in T-cells and NK cells. During T-cell mediated immune response may inhibit dendritic cells (DC) activation and maturation. {ECO:0000250, ECO:0000269|PubMed:11081504, ECO:0000269|PubMed:15178704}.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Inflammatory bowel disease (IBD) - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;Allograft Rejection
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.310
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.0621
- hipred
- N
- hipred_score
- 0.299
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.949
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Il21
- Phenotype
- hematopoietic system phenotype; normal phenotype; immune system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- positive regulation of cytokine production;immune response;signal transduction;tyrosine phosphorylation of STAT protein;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of B cell proliferation;positive regulation of interleukin-17 production;positive regulation of tissue remodeling;interleukin-21-mediated signaling pathway;positive regulation of T cell proliferation;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of interferon-gamma biosynthetic process;positive regulation of natural killer cell mediated cytotoxicity;cell maturation;positive regulation of inflammatory response
- Cellular component
- extracellular region;extracellular space
- Molecular function
- cytokine activity;cytokine receptor binding;interleukin-2 receptor binding